Unknown PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT01446614

Mesenchymal Stem Cells Transplantation to Patients With Parkinson's Disease

PhaseⅠ/ⅡTrial of Autologous Bone Marrow Derived Mesenchymal Stem Cells to Patients With Parkinson's Disease.

Sponsor: Guangzhou General Hospital of Guangzhou Military Command

Interventions bone marrow derived mesenchymal stem cells

Updated 4 times since 2017 Last updated: Oct 4, 2011 Started: Oct 31, 2011 Primary completion: Jun 30, 2013 Completion: Jun 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01446614, this PHASE1/PHASE2 trial focuses on Parkinson's Disease and remains ongoing. Sponsored by Guangzhou General Hospital of Guangzhou Military Command, it has been updated 4 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Guangzhou General Hospital of Guangzhou Military Command

Data source: Guangzhou General Hospital of Guangzhou Military Command

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China